Tikun Olam

Medical Cannabis

Health Tech & Life Sciences
Acquired by Cannbit on Nov, 2019
Public Nof HaGalil Founded 2006
Total raised
Stage
Public
Founded
2006
Headcount
24
HQ
Nof HaGalil
Sector
Health Tech & Life Sciences

About

Tikun Olam specializes in breeding proprietary cannabis strains and developing standardized, accurately dosed products. The companys production techniques are focused on increasing the efficacy of the plants active ingredients. Tikun Olams products are used in a number of ongoing clinical trials in Israels regulated medical cannabis market. Tikun Olam also operates Tikun Olam Care, a professional cannabis nursing clinic that provides safe and personalized treatment for a variety of medical conditions to more than 20,000 patients of all ages. In early 2020, Cannbit Pharmaceuticals acquired Tikun Olam for $23 million, in addition to 5% of the its shares and other amounts based on the companys success.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Tikun Olam acquired and by whom?
Tikun Olam was acquired by Cannbit Pharmaceuticals in November 2019 for $23 million, plus 5% of Cannbit's shares and additional amounts contingent on Tikun Olam's success.
What was a significant operational development for Tikun Olam in early 2020?
In January 2020, Tikun Olam underwent a reverse merger and became publicly traded on the TASE under the ticker TKUN.
What partnership did Tikun Olam-Cannbit sign in December 2021?
In December 2021, Tikun Olam-Cannbit signed a medical cannabis agreement with Teva.
Which international markets did Tikun Olam expand into in May 2021?
In May 2021, Tikun Olam signed deals to supply products to the UK and export to Brazil's market.
What agreement did Tikun Olam make with an Israeli health fund in January 2021?
In January 2021, Tikun Olam announced it would issue medical cannabis for members of the Meuhedet health fund.
What partnership did Tikun Olam announce in October 2020 for the US market?
In October 2020, Tikun Olam partnered with Maine Grown to produce medical and adult-use cannabis products for the state of Maine.
What significant deal did Cannbit, after acquiring Tikun Olam, sign in September 2020?
In September 2020, Cannbit signed an agreement with Super-Pharm, valued at over NIS 100 million.
What issue did Tikun Olam face with the Health Ministry in November 2018?
In November 2018, the Health Ministry temporarily closed Tikun Olam's cannabis farm.
When did Tikun Olam announce its first US partnership?
Tikun Olam announced its first US partnership in January 2015.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Agriculture & Food TechnologiesAg TechFarm Equipment & TreatmentHealth Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Materials & SubstancesRaw Materials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B2CB2B

Tags

biotechnologycropspharmaceuticalscannabisbreedingagtechmedical-cannabiscancer